Classification Term: 3423

Acylaminobenzoic acid and derivatives (ontology term: CHEMONTID:0004361)

Derivatives of amino benzoic acid derivatives where the amine group is N-acylated." []

found 51 associated metabolites at category metabolite taxonomy ontology rank level.

Child Taxonomies: There is no child term of current ontology term.

Antimycin A

N-{7-hexyl-4,9-dimethyl-8-[(3-methylbutanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzene-1-carboximidate

C28H40N2O9 (548.273367)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

2-(Malonylamino)benzoic acid

2-[(2-Carboxyacetyl)amino]benzenecarboxylic acid

C10H9NO5 (223.04807039999997)

2-(Malonylamino)benzoic acid is found in nuts. 2-(Malonylamino)benzoic acid is isolated from the leaves of the peanut (Arachis hypogaea). Isolated from the leaves of the peanut (Arachis hypogaea). N-Malonylanthranilic acid is found in nuts.

Metrizoic acid

3-(Acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoic acid

C12H11I3N2O4 (627.7853096)

V - Various > V08 - Contrast media > V08A - X-ray contrast media, iodinated > V08AA - Watersoluble, nephrotropic, high osmolar x-ray contrast media D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids ATC code: V08AA02

N-acetyl-5-aminosalicylic acid

N-Acetyl-5-aminosalicylic acid, monosodium salt

C9H9NO4 (195.0531554)

N-acetyl-5-aminosalicylic acid is a metabolite of mesalazine. Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is an anti-inflammatory drug used to treat inflammatory bowel disease, such as ulcerative colitis and mild-to-moderate Crohns disease. Mesalazine is a bowel-specific aminosalicylate drug that acts locally in the gut and has its predominant actions there, thereby having few systemic side effects. (Wikipedia) D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

N-Acetylprocainamide

N-(4-{[2-(diethylamino)ethyl]carbamoyl}phenyl)ethanimidic acid

C15H23N3O2 (277.1790178)

N-Acetylprocainamide (NAPA or acecainide) is the N-acetylated metabolite of procainamide. It is a Class III antiarrhythmic agent, whereas procainamide is a Class Ia antiarrhythmic drug. It is only partially as active as procainamide; when checking levels both must be included in the final calculation. C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker

2-[Methyl(3-phenylpropanoyl)amino]benzoic acid

2-(Methyl-(3-phenylpropanoyl)amino)benzoic acid

C17H17NO3 (283.1208372)

2-[Methyl(3-phenylpropanoyl)amino]benzoic acid is produced by the marine Streptomyces sp. B7747.

Purothionin AII

N-[(3S,4R,7R,8R,9S)-7-Butyl-4,9-dimethyl-8-[(3-methylbutanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzene-1-carboximidate

C26H36N2O9 (520.2420686)

Isolated from wheat (Triticum monococcum). Toxic to brewers yeast. Purothionin AII is found in wheat, cereals and cereal products, and common wheat. Purothionin AII is found in cereals and cereal products. Purothionin AII is isolated from wheat (Triticum monococcum). Toxic to brewers yeast.

Methyl n-acetylanthranilate

Anthranilic acid, N-acetyl-, methyl ester (8ci)

C10H11NO3 (193.0738896)

Methyl n-acetylanthranilate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

Methyl n-formylanthranilate

Benzoic acid, 2-(formylamino)-, methyl ester

C9H9NO3 (179.05824040000002)

Methyl n-formylanthranilate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

Iodipamide

3-{5-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]pentanamido}-2,4,6-triiodobenzoic acid

C20H14I6N2O6 (1139.5120444)

Iodipamide is only found in individuals that have used or taken this drug. It is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography. [PubChem]Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these iodinated organic compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. Iodipamides primary excretion through the hepato-biliary system and concentration in bile allows visualization of the gallbladder and biliary ducts. V - Various > V08 - Contrast media > V08A - X-ray contrast media, iodinated > V08AC - Watersoluble, hepatotropic x-ray contrast media D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids

Iodixanol

5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

C35H44I6N6O15 (1549.7133134000003)

Iodixanol is only found in individuals that have used or taken this drug. It is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents.Organic iodine compounds attenuate x-rays as they pass through the body, thereby allowing the body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. After intravascular administration, iodixanol makes opaque those internal structures in its path of flow, allowing their visualization until significant hemodilution and elimination occur. V - Various > V08 - Contrast media > V08A - X-ray contrast media, iodinated > V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids

Coutaric acid

4-[(2R)-2-(Aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-YL]-3-[(1-ethylpropyl)amino]benzoic acid

C18H27N3O4 (349.2001462)

Coutaric acid is a fecal metabolite from grape juice. It may also be in urine. It is an ester formed from coumaric acid and tartaric acid.

Avenanthramide L

5-Hydroxy-2-{[(2E,4E)-1-hydroxy-5-(4-hydroxyphenyl)penta-2,4-dien-1-ylidene]amino}benzoate

C18H15NO5 (325.095018)

Avenanthramide L is found in cereals and cereal products. Avenanthramide L is isolated from oat, Avena sativa, inoculated with Puccinia coronata f. sp. avenae. Isolated from oat, Avena sativa, inoculated with Puccinia coronata f.species avenae. Avenanthramide L is found in oat and cereals and cereal products.

Iopentol

N1,N3-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxy-3-methoxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboximidic acid

C20H28I3N3O9 (834.8959768000001)

V - Various > V08 - Contrast media > V08A - X-ray contrast media, iodinated > V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids Iopentol is a molecule used as a contrast medium.

N-Acetyl-3-hydroxyprocainamide

N-[2-(diethylamino)ethyl]-3-hydroxy-4-[(1-hydroxyethylidene)amino]benzene-1-carboximidic acid

C15H23N3O3 (293.1739328)

N-Acetyl-3-hydroxyprocainamide is a metabolite of procainamide. Procainamide is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias, classified by the Vaughan Williams classification system as class Ia. (Wikipedia)

Avenanthramide P

5-Hydroxy-2-{[(2E,4E)-1-hydroxy-5-(4-hydroxy-3-methoxyphenyl)penta-2,4-dien-1-ylidene]amino}benzoate

C19H17NO6 (355.1055822)

5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

5-(Acetylamino)-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

C16H20I3N3O7 (746.84355)

4-Acetylaminohippuric acid

2-[(4-acetamidophenyl)formamido]acetic acid

C11H12N2O4 (236.07970319999998)

2-Hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid

2-hydroxy-4-{2-[(4-methylbenzenesulfonyl)oxy]acetamido}benzoic acid

C16H15NO7S (365.05692)

3-Maleimidobenzoic acid N-hydroxysuccinimide ester

2,5-dioxopyrrolidin-1-yl 3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate

C15H10N2O6 (314.05388400000004)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide

N-hydroxy-4-[(3-methyl-2-phenylbutanoyl)amino]benzamide

C18H20N2O3 (312.147385)

Ethyl 4-[[2-[[(5Z)-5-(2,6-dioxo-1,3-dipropylpurin-8-ylidene)-1-methyl-2H-pyrazol-3-yl]oxy]acetyl]amino]benzoate

ethyl 4-(2-{[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]oxy}acetamido)benzoate

C26H31N7O6 (537.2335706)

4-[[2-[[(5Z)-5-(2,6-Dioxo-1,3-dipropylpurin-8-ylidene)-1-methyl-2H-pyrazol-3-yl]oxy]acetyl]amino]benzoic acid

4-(2-{[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]oxy}acetamido)benzoic acid

C24H27N7O6 (509.20227220000004)

(E)-2-(3-(Naphthalen-2-yl)but-2-enamido)benzoic acid

2-[[3-(2-Naphthalenyl)-1-oxobut-2-enyl]amino]benzoate

C21H17NO3 (331.1208372)

Isophthalamide, N,N'-bis(2,3-dihydroxypropyl)-5-(N-(2-hydroxyethyl)acetamido)-2,4,6-triiodo-

N1,N3-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboximidate

C18H24I3N3O8 (790.8697634)

D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids

Desethyl-N-acetylprocainamide

4-acetamido-N-[2-(ethylamino)ethyl]benzamide

C13H19N3O2 (249.1477194)

Iocarmic acid

3-[(5-{[3-carboxy-2,4,6-triiodo-5-(methyl-C-hydroxycarbonimidoyl)phenyl]-C-hydroxycarbonimidoyl}-1-hydroxypentylidene)amino]-2,4,6-triiodo-5-(methyl-C-hydroxycarbonimidoyl)benzoic acid

C24H20I6N4O8 (1253.5549700000001)

Iodipamide ethyl ester

ethyl 3-(5-{[3-(ethoxycarbonyl)-2,4,6-triiodophenyl]carbamoyl}pentanamido)-2,4,6-triiodobenzoate

C24H22I6N2O6 (1195.5746411999999)

D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids

Iodoxamic acid

3-{16-[(3-carboxy-2,4,6-triiodophenyl)-C-hydroxycarbonimidoyl]-2-hydroxy-5,8,11,14-tetraoxa-1-azahexadec-1-en-1-yl}-2,4,6-triiodobenzoic acid

C26H26I6N2O10 (1287.5855996)

V - Various > V08 - Contrast media > V08A - X-ray contrast media, iodinated > V08AC - Watersoluble, hepatotropic x-ray contrast media D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids

Ioglunide

N-(2-hydroxyethyl)-2,4,6-triiodo-3-(N-methylacetamido)-5-(2,3,4,5,6-pentahydroxyhexanamido)benzamide

C18H24I3N3O9 (806.8646784)

Ioglycamic Acid

3-[(2-{[(3-carboxy-2,4,6-triiodophenyl)-C-hydroxycarbonimidoyl]methoxy}-1-hydroxyethylidene)amino]-2,4,6-triiodobenzoate

C18H10I6N2O7 (1127.4756610000002)

Iomeprol

N1,N3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-methylacetamido)-2,4,6-triiodobenzene-1,3-dicarboximidic acid

C17H22I3N3O8 (776.8541142000001)

Iopamidol

N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-[(1,2-dihydroxypropylidene)amino]-2,4,6-triiodobenzene-1,3-dicarboximidate

C17H22I3N3O8 (776.8541142000001)

Iosimenol

5-[2-({3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}(2,3-dihydroxypropyl)carbamoyl)-N-(2,3-dihydroxypropyl)acetamido]-N1-(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

C31H36I6N6O14 (1477.6558016)

Iosulamide

3-{[3-(2-{[3-carboxy-5-(N-ethylacetamido)-2,4,6-triiodophenyl]-C-hydroxycarbonimidoyl}ethanesulphonyl)-1-hydroxypropylidene]amino}-5-(N-ethylacetamido)-2,4,6-triiodobenzoic acid

C28H28I6N4O10S (1373.5794688)

D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids

Iotalamic acid

3-[(1-Hydroxyethylidene)amino]-2,4,6-triiodo-5-(methyl-C-hydroxycarbonimidoyl)benzoate

C11H9I3N2O4 (613.7696604)

Iotrolan

2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)-C-hydroxycarbonimidoyl]phenyl})carbamoyl]acetamido}-N1,N3-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboximidic acid

C37H48I6N6O18 (1625.7293568)

Iotroxate

2-{11-[(2-carboxy-3,5,6-triiodophenyl)-C-hydroxycarbonimidoyl]-2-hydroxy-4,7,10-trioxa-1-azaundec-1-en-1-yl}-3,4,6-triiodobenzoate

C22H18I6N2O9 (1215.5280877999999)

Ioversol

N1,N3-Bis(2,3-dihydroxypropyl)-5-[2-hydroxy-N-(2-hydroxyethyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboximidate

C18H24I3N3O9 (806.8646784)

Ioxaglic acid

3-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodo-5-(2-{[2,4,6-triiodo-3-(methylcarbamoyl)-5-(N-methylacetamido)phenyl]formamido}acetamido)benzoic acid

C24H21I6N5O8 (1268.5658686000002)

Ioxilan

N1-(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-N3-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

C18H24I3N3O8 (790.8697634)

Lanreotide

2-{[(19-{[2-amino-1-hydroxy-3-(naphthalen-2-yl)propylidene]amino}-10-(4-aminobutyl)-6,9,12,15,18-pentahydroxy-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-4-yl)(hydroxy)methylidene]amino}-3-hydroxybutanimidate

C54H69N11O10S2 (1095.4670054)

H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01C - Hypothalamic hormones > H01CB - Somatostatin and analogues D000970 - Antineoplastic Agents